| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_855768e0fdbb1c588d7cc92ac6db64a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c9e7dc412e4b3cf41a39fd2742aca3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3ab78d8b4ecedaaafbf00d4eacff010 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate |
2012-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f7526d43dfba3dcecc24d7c71988770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3430a142059e3db7db54105003a0e1 |
| publicationDate |
2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012112696-A1 |
| titleOfInvention |
Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
| abstract |
The present application relates to the use of bacterial minicells as targeted delivery agents in vivo and in vitro. Described herein are genetically engineered eubacterial minicells designed to preferentially target and deliver therapeutically relevant agents using a minicell surface coupling molecule capable of binding and displaying antibodies or other Fc-containing targeting moiety fusions and conjugates. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10124024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102558941-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017239542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016301302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994014-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017024059-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10919942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180056642-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108348624-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108348624-A |
| priorityDate |
2011-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |